SCHEMBL20760640

SCHEMBL20760640

Cn1c2nc(S(=O)(=O)c3ccccc3)sc2c2cn[nH]c(=O)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.38
HSD17B10 Q99714 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 4/20 0.35
TSHR P16473 3/20 0.35
KDM4A O75164 1/20 0.35
LMNA P02545 1/20 0.35
PAX8 Q06710 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
POLB P06746 1/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CCNE2 O96020 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20745467 0.83 ALDH1A1 (0.33) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20761352 0.81 ALDH1A1 (0.32) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20758619 0.81 KDM4E (0.35) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL24719758 0.80 KDM4E (0.35) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20745521 0.79 KDM4E (0.46) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL30119061 0.76 HSD17B10 (0.39) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20745408 0.76 KDM4E (0.33) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20745433 0.76 KDM4E (0.37) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL20761543 0.75 SMN1; SMN2 (0.35) KDM4EHSD17B10TDP1CYP1A2CYP2C9
SCHEMBL25019817 0.75 KDM4E (0.37) KDM4EHSD17B10TDP1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668881-B1 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS AGIOS PHARMACEUTICALS INC (US) 2023-10-04 EP disclosed
WO-2019035863-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS AGIOS PHARMACEUTICALS, INC. (US) 2019-02-21 WO disclosed